GLP-1 Drug Breaks Liver Cancer's Drug Resistance via Metabolic Pathway
GLP-1 receptor agonists may overcome Lenvatinib resistance in hepatocellular carcinoma by targeting a key glycolytic vulnerability.
482 articles in this topic
GLP-1 receptor agonists may overcome Lenvatinib resistance in hepatocellular carcinoma by targeting a key glycolytic vulnerability.
Corticosterone triggered by gut microbiome-derived phage DNA disables B cell tumor immunity, revealing a stress-cancer axis.
A new study finds elevated LDL, total cholesterol, and triglycerides significantly raise colorectal adenoma risk — a key cancer precursor.
A Chinese cohort study reveals the cancer risk landscape for patients with autoimmune gastritis, a condition frequently underdiagnosed in Asian populations.
Spatial-EV-seq charts where cancer-shielding vesicles cluster in tissue, exposing why immunotherapy fails in some tumor zones.
A sex-specific GABA signaling pathway supercharges immune suppression in female glioblastoma, revealing a potential new immunotherapy target.
The FDA has greenlighted a new active sunscreen ingredient, the first approval of its kind in years, expanding UV protection options.
A newly discovered phage-fibroblast-B cell circuit explains how chronic stress drives tumor growth by suppressing anti-tumor immunity.
A clinical trial shows 4g/day icosapent ethyl nearly tripled marine omega-3 content in colorectal tissue, shifting the omega-3/omega-6 ratio favorably.
A ddPCR assay targeting methylated ctDNA detects sarcoma in blood with 74% sensitivity and predicts treatment outcomes.
Scientists expand granulocyte-monocyte progenitors into a scalable CAR platform that infiltrates tumors and fights leukemia and solid cancers.
MD Anderson researchers reveal a feedback loop between cuproptosis and CD8+ T cells that could unlock new combination therapies for immune-resistant tumors.